INTERNATIONAL JOURNAL OF HYPERTHERMIA

Scope & Guideline

Innovating treatment through the power of heat.

Introduction

Delve into the academic richness of INTERNATIONAL JOURNAL OF HYPERTHERMIA with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0265-6736
PublisherTAYLOR & FRANCIS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1985 to 2024
AbbreviationINT J HYPERTHER / Int. J. Hyperthermia
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The International Journal of Hyperthermia focuses on the application of hyperthermia in medical treatments, particularly in oncology. The journal encompasses a wide range of research areas related to thermal therapy, emphasizing both clinical and experimental studies that explore the efficacy, safety, and technological advancements in hyperthermia and related ablative techniques.
  1. Thermal Ablation Techniques:
    The journal extensively covers various thermal ablation methods like high-intensity focused ultrasound (HIFU), microwave ablation, and radiofrequency ablation, detailing their efficacy in treating different types of tumors.
  2. Clinical Applications and Outcomes:
    A significant focus on clinical outcomes related to hyperthermia, including studies on patient safety, treatment efficacy, and long-term follow-up results in various cancers, particularly hepatocellular carcinoma and thyroid cancers.
  3. Technological Innovations:
    Research on novel technologies and methodologies for enhancing hyperthermia treatments, including imaging techniques for guidance and monitoring, as well as the development of new devices and protocols.
  4. Mechanistic Studies:
    Investigations into the biological mechanisms underlying the effects of hyperthermia and thermal treatments, including cellular responses, immune responses, and molecular pathways.
  5. Combination Therapies:
    Exploration of the synergistic effects of combining hyperthermia with other treatment modalities such as chemotherapy, radiotherapy, and immunotherapy to improve patient outcomes.
The International Journal of Hyperthermia has seen a significant evolution in its research focus, with emerging themes reflecting the latest advancements and interests in the field of thermal therapies.
  1. Personalized Medicine Approaches:
    An increasing trend towards personalized treatment strategies in hyperthermia, incorporating patient-specific factors and genetic profiles to optimize therapeutic outcomes.
  2. Integration of Imaging Techniques:
    Emerging emphasis on utilizing advanced imaging techniques, such as MRI and ultrasound, for accurate monitoring and guidance during hyperthermia treatments, enhancing precision and safety.
  3. Immunotherapy Synergies:
    A growing body of research exploring the combination of hyperthermia with immunotherapeutic agents, highlighting the potential to enhance immune responses against tumors.
  4. Novel Drug Delivery Systems:
    Investigations into innovative drug delivery systems in conjunction with hyperthermia, such as thermosensitive liposomes or nanoparticles, to improve therapeutic efficacy.
  5. Real-Time Monitoring Technologies:
    Increased focus on the development of real-time monitoring technologies for thermal therapies, allowing for dynamic adjustments during treatment to enhance effectiveness and minimize damage to surrounding tissues.

Declining or Waning

While the journal has consistently focused on the advancements in hyperthermia and related therapies, some areas have seen a decline in frequency of publication, indicating shifting research priorities or saturation of certain topics.
  1. Non-Oncological Applications:
    Research related to non-oncological applications of hyperthermia, such as in rheumatic diseases or other non-cancerous conditions, has been less prominent compared to the emphasis on oncological treatments.
  2. Basic Science Studies:
    There is a noticeable decrease in basic science studies focused on thermal physics or biophysics of hyperthermia, as the journal has shifted towards clinical and translational research.
  3. Longitudinal Studies on Thermal Effects:
    Long-term studies assessing the chronic effects of hyperthermia or thermal damage on tissues have become less frequent, possibly due to a shift towards immediate clinical outcomes.
  4. Historical Reviews and Meta-Analyses:
    The publication of broad historical reviews or comprehensive meta-analyses on previously established techniques is declining, as the journal prioritizes innovative and novel research findings.

Similar Journals

Radiation Oncology

Empowering oncology with open access to groundbreaking research.
Publisher: BMCISSN: Frequency: 1 issue/year

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

Heart Rhythm O2

Exploring the future of cardiology through high-impact studies.
Publisher: ELSEVIERISSN: 2666-5018Frequency: 6 issues/year

Heart Rhythm O2, published by Elsevier and indexed under ISSN 2666-5018, is a premier Open Access journal that has established itself as a vital platform for the dissemination of innovative research in Cardiology and Cardiovascular Medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a distinguished Q1 ranking in its field as of 2023, underscoring its commitment to excellence and quality. Operating from its base in the Netherlands, Heart Rhythm O2 aims to bridge the gap between clinical practice and emerging scientific findings, fostering collaboration among researchers, healthcare professionals, and students globally. With a focus on high-impact original research, review articles, and clinical studies, the journal is dedicated to advancing our understanding of cardiac rhythm management and cardiovascular health. With open access options, it ensures that vital knowledge is freely available, facilitating the ongoing education and engagement of the medical community worldwide.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Advancing the Frontiers of Electrophysiology
Publisher: WILEYISSN: 1045-3873Frequency: 12 issues/year

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, published by Wiley, stands at the forefront of the fields of Cardiology and Cardiovascular Medicine, boasting an impressive Impact Factor that reflects its scholarly influence. With a strong focus on innovative research, this esteemed journal has been a vital resource for advancing our understanding of electrophysiological concepts since its inception in 1990. As a Q1 journal in both Cardiology and Physiology (medical) as of 2023, it provides a platform for cutting-edge discoveries and comprehensive reviews that cater to the academic and clinical needs of researchers, practitioners, and students alike. The journal features rigorous peer-reviewed articles that delve into various aspects of cardiovascular health, enhancing both theoretical knowledge and clinical application. Although it does not offer open access, it remains a key resource for those engaged in cardiovascular research, published quarterly through 2024 to ensure timely dissemination of high-quality findings.

Case Reports in Oncology

Unlocking Insights in Oncology
Publisher: KARGERISSN: 1662-6575Frequency: 3 issues/year

Case Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.

ONCOLOGY

Elevating the standards of oncology research and practice.
Publisher: KARGERISSN: 0030-2414Frequency: 12 issues/year

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

Molecular Imaging and Radionuclide Therapy

Innovating the future of nuclear medicine and imaging.
Publisher: GALENOS PUBL HOUSEISSN: 2146-1414Frequency: 3 issues/year

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

Indian Journal of Gynecologic Oncology

Exploring innovations in gynecologic cancer care.
Publisher: SPRINGER INDIAISSN: 2363-8397Frequency: 1 issue/year

Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.

Japanese Journal of Radiology

Fostering Global Dialogue in Medical Imaging
Publisher: SPRINGERISSN: 1867-1071Frequency: 10 issues/year

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

PHLEBOLOGY

Unveiling breakthroughs in venous disorder treatment.
Publisher: SAGE PUBLICATIONS INCISSN: 0268-3555Frequency: 8 issues/year

PHLEBOLOGY is a renowned academic journal published by SAGE Publications Inc. that focuses on the evolving field of phlebology and related cardiovascular issues. With an ISSN of 0268-3555 and an E-ISSN of 1758-1125, this journal serves as a pivotal platform for disseminating high-quality research, clinical findings, and innovative practices in venous disease management and treatment. Operating from the United Kingdom, tasked with a mission to advance the scientific understanding and clinical practice surrounding venous disorders, PHLEBOLOGY is currently ranked in the Q3 category for both Cardiology and Cardiovascular Medicine, as well as in Medicine (miscellaneous) for 2023. Its Scopus rank of #192 out of 387 highlights its commitment to excellence, ensuring that it reaches a respectable 50th percentile within its fields. Although it does not offer open access, the journal invites contributions from researchers, healthcare professionals, and students, fostering a community dedicated to improving patient outcomes and promoting evidence-based practices in venous health.

Radiologia Medica

Elevating Medical Imaging Research Since 1947.
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0033-8362Frequency: 12 issues/year

Radiologia Medica, published by Springer-Verlag Italia SRL, is a premier Italian journal dedicated to the field of radiology, nuclear medicine, and imaging. With a rich history dating back to 1947, this journal has consistently provided cutting-edge research and findings, contributing significantly to advancements in medical imaging techniques and practices. As evidenced by its impressive Q1 rankings in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine and Imaging, Radiologia Medica holds a prestigious position within the top tier of medical journals, ranked #11 out of 333 in its category and residing in the 96th percentile according to Scopus metrics. Although it is not currently offered as an Open Access journal, its robust subscription model supports extensive research dissemination. Researchers, professionals, and students alike will find invaluable insights and knowledge critical for advancing their understanding and practice within this dynamic field. Situated in Milan, Italy, Radiologia Medica continues to be an influential platform for the exchange of high-quality research, bridging various disciplines and promoting excellence in radiological science.